Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite

Department of Paediatrics, University of Gottingen, Germany.

Patients with craniopharyngioma frequently suffer from severe obesity. Leptin induces an inhibition of appetite via hypothalamic receptors. This study was undertaken to investigate whether a relationship exists between serum leptin levels and pituitary/hypothalamic lesions in craniopharyngioma patients. Serum leptin levels were evaluated by RIA in 14 patients (age 7-21 years; 7 females, 7 males) after they had undergone neurosurgical treatment for craniopharyngioma. Normal controls had a positive correlation between leptin levels and body mass index (BMI) with higher levels in the females than in the males. Significantly elevated leptin levels with respect to BMI were found in 11 craniopharyngioma patients who had been affected by a suprasellar tumour, whereas 3 patients with an intrasellar tumour had lower, almost normal serum leptin levels. Our data suggest that craniopharyngioma patients develop hypothalamic obesity because their hypothalamic structures are insensitive to endogenous leptin. The elevated serum leptin concentrations found only in patients with a suprasellar tumour may be explained by a disturbed feedback mechanism from the hypothalamic leptin receptors to the adipose tissue.

This article has been cited by other articles:

				M G. Shaikh, R. G Grundy, and J. M W Kirk Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children Eur. J. Endocrinol., December 1, 2008; 159(6): 791 - 797. [Abstract] [Full Text] [PDF]

				M. G. Shaikh, R. G. Grundy, and J. M. W. Kirk Reductions in Basal Metabolic Rate and Physical Activity Contribute to Hypothalamic Obesity J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2588 - 2593. [Abstract] [Full Text] [PDF]

				R. Brauner, C. Trivin, M. Zerah, J.-C. Souberbielle, F. Doz, C. Kalifa, and C. Sainte-Rose Diencephalic Syndrome due to Hypothalamic Tumor: A Model of the Relationship between Weight and Puberty Onset J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2467 - 2473. [Abstract] [Full Text] [PDF]

				N. Karavitaki, S. Cudlip, C. B. T. Adams, and J. A. H. Wass Craniopharyngiomas Endocr. Rev., June 1, 2006; 27(4): 371 - 397. [Abstract] [Full Text] [PDF]

				C. Daousi, I. A. MacFarlane, P. J. English, J. P. H. Wilding, M. Patterson, T. M. Dovey, J. C. G. Halford, M. A. Ghatei, and J. H. Pinkney Is There a Role for Ghrelin and Peptide-YY in the Pathogenesis of Obesity in Adults with Acquired Structural Hypothalamic Damage? J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5025 - 5030. [Abstract] [Full Text] [PDF]

				J. Verhelst, P. Kendall-Taylor, E. M. Erfurth, D. A. Price, M. Geffner, M. Koltowska-Haggstrom, P. J. Jonsson, P. Wilton, and R. Abs Baseline Characteristics and Response to 2 Years of Growth Hormone (GH) Replacement of Hypopituitary Patients with GH Deficiency due to Adult-Onset Craniopharyngioma in Comparison with Patients with Nonfunctioning Pituitary Adenoma: Data from KIMS (Pfizer International Metabolic Database) J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4636 - 4643. [Abstract] [Full Text] [PDF]

				M. Geffner, M. Lundberg, M. Koltowska-Haggstrom, R. Abs, J. Verhelst, E. M. Erfurth, P. Kendall-Taylor, D. A. Price, P. Jonsson, and B. Bakker Changes in Height, Weight, and Body Mass Index in Children with Craniopharyngioma after Three Years of Growth Hormone Therapy: Analysis of KIGS (Pfizer International Growth Database) J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5435 - 5440. [Abstract] [Full Text] [PDF]

				H. L. Muller, A. Emser, A. Faldum, G. Bruhnken, N. Etavard-Gorris, U. Gebhardt, R. Oeverink, R. Kolb, and N. Sorensen Longitudinal Study on Growth and Body Mass Index before and after Diagnosis of Childhood Craniopharyngioma J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3298 - 3305. [Abstract] [Full Text] [PDF]

				K. J. Harz, H. L. Muller, E. Waldeck, V. Pudel, and C. Roth Obesity in Patients with Craniopharyngioma: Assessment of Food Intake and Movement Counts Indicating Physical Activity J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5227 - 5231. [Abstract] [Full Text] [PDF]

				A. Snow, E. Gozal, A. Malhotra, D. Tiosano, R. Perlman, C. Vega, E. Shahar, D. Gozal, Z.'e. Hochberg, and G. Pillar Severe Hypersomnolence After Pituitary/Hypothalamic Surgery in Adolescents: Clinical Characteristics and Potential Mechanisms Pediatrics, December 1, 2002; 110(6): e74 - 74. [Abstract] [Full Text] [PDF]

				P. W. Mason, N. Krawiecki, and L. R. Meacham The Use of Dextroamphetamine to Treat Obesity and Hyperphagia in Children Treated for Craniopharyngioma Arch Pediatr Adolesc Med, September 1, 2002; 156(9): 887 - 892. [Abstract] [Full Text] [PDF]

				A. P Goldstone, A. E Brynes, E L. Thomas, J. D Bell, G. Frost, A. Holland, M. A Ghatei, and S. R Bloom Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome Am. J. Clinical Nutrition, March 1, 2002; 75(3): 468 - 475. [Abstract] [Full Text] [PDF]